Lasa Supergenerics Ltd (LASA) — Board Meeting | 9 September 2026(2 announcements)

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approved 11th AGM on September 30, 2026 with key director appointments and resolutions
🔄 What Changed
Re-appointment of Director Omkar Herlekar and appointment of Janardan Savala as Executive Director
🔮 What's Next
AGM scheduled for September 30, 2026; donation limit set at ₹2 crore annually; managerial remuneration approved up to ₹3 crore
💡 Investor Takeaway
Shareholders must vote remotely via e-voting platforms before September 29, 2026 to approve key appointments and resolutions.

Lasa Supergenerics announced its 11th Annual General Meeting scheduled for September 30, 2026 via video conferencing, with resolutions including director re-appointments, secretarial auditor appointment, new executive director hiring, donation approvals up to ₹2 crore, managerial remuneration up to ₹3 crore, and enhanced borrowing powers. The notice details voting procedures, shareholder record dates, and compliance requirements for physical and demat shareholders.

2 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Lasa Supergenerics announces 11th AGM scheduled for September 30, 2026 via video conferencing
🔄 What Changed
Re-appointment of Omkar Herlekar as Director; appointment of Janardan Savala as Whole-time Director; approval of ₹3 crore director remuneration; ₹2 crore donation authorization
🔮 What's Next
AGM scheduled for September 30, 2026
💡 Investor Takeaway
Shareholders must register PAN, KYC, and nominations to vote electronically at the AGM.

Lasa Supergenerics announced its 11th Annual General Meeting scheduled for September 30, 2026 via video conferencing, with resolutions including re-appointment of Director Omkar Herlekar, appointment of Janardan Savala as Whole-time Director, approval of director remuneration up to ₹3 crore, and donations up to ₹2 crore to charitable trusts. The meeting will close the share register from September 23-29, 2026.

About Lasa Supergenerics Ltd (LASA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹31.41 Cr ROE: -20.2% ROCE: -17.9%

View full LASA stock details →

📡 Get AI alerts when LASA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LASA — Free

📊 More LASA filings

See all LASA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LASA files new disclosures

Track LASA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LASA — Free

Free account · 2 AI queries/day